1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The Midostaurin API market is evolving as stakeholders adapt to changing clinical, regulatory, and commercial demands. Senior decision-makers face a complex landscape shaped by innovation, supply optimization, and shifting external influences.
Market Snapshot: Midostaurin API Market Landscape
The Midostaurin API market is experiencing robust growth, primarily driven by rising incidence of acute myeloid leukemia and systemic mastocytosis. Market activity is further fueled by rising demand for FLT3 inhibitors, technological process enhancements, and increased attention to regulatory compliance. Attractive opportunities continue to emerge for providers who optimize cost-effectiveness, production reliability, and partnership integration, particularly in high-incidence regions.
Scope & Segmentation
- Indication: Acute Myeloid Leukemia, Systemic Mastocytosis
- Line of Therapy: First Line, Second Line and Beyond
- Distribution Channel: Hospital Pharmacy, Retail Pharmacy
- Formulation: Intravenous, Oral (Including Capsule and Tablet)
- Patient Type: Adult, Pediatric
- Geographic Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Key Companies Covered: Pfizer Inc., Aurobindo Pharma Limited, Viatris Inc., Sun Pharmaceutical Industries Limited, Cipla Limited, Natco Pharma Limited, Jubilant Life Sciences Limited, Hetero Drugs Limited, Zydus Lifesciences Limited, Teva Pharmaceutical Industries Ltd.
Advances in continuous flow chemistry and process intensification, together with increasing regulatory scrutiny and global partnerships, set the direction for both manufacturers and investors.
Key Takeaways for Senior Decision-Makers
- Technological breakthroughs are raising the bar for process efficiency, reducing solvent and impurity levels in Midostaurin API production.
- Heightened global regulatory expectations necessitate sophisticated analytical controls and alignment to current ICH guidelines.
- Consolidation is active among contract development and manufacturing organizations (CDMOs) and API suppliers, enabling economies of scale and expanded service capabilities.
- Strategic partnerships—across API providers, pharmaceutical firms, and biotechnology companies—facilitate technology transfer, process intensification, and sustainability adoption.
- Segmented opportunities arise due to variable demand between first- and second-line therapies, as well as formulation and patient type (notably pediatric needs).
- Regional market performance varies significantly, with the Americas supported by strong regulatory infrastructure, EMEA markets requiring a two-tiered approach, and Asia-Pacific presenting growth through oncology programs and favorable policies.
Tariff Impact on Midostaurin API Supply Chains
Forthcoming U.S. tariff revisions for 2025 introduce new complexity to the Midostaurin API ecosystem. Increased duties on certain intermediates are prompting producers to diversify sourcing or invest in domestic and nearshore capacity. These shifts trigger renegotiations, cost structure adjustments, and enhanced supply chain transparency, as well as consideration of vertical integration to reduce exposure and bolster intellectual property security.
Methodology & Data Sources
This report is underpinned by primary research—through executive interviews with industry leaders and functional experts—and extensive secondary research including regulatory filings, white papers, and scientific literature. Insights are triangulated, validated by subject-matter authorities, and statistically verified to ensure accuracy and reliability throughout.
Why This Report Matters
- Provides a structured framework for identifying actionable opportunities and mitigating operational and commercial risk within the Midostaurin API market.
- Equips senior executives with segment-specific intelligence, including the impact of regulatory evolution, technological shifts, and regional market patterns.
- Supports informed decision-making for partnerships, investment, production scaling, and supply chain optimization, reinforced by rigorous methodology.
Conclusion
The Midostaurin API market is advancing through innovation, regulatory change, and dynamic supply considerations. Proactive engagement, robust partnerships, and agile strategies will be essential in capturing sustained value as the sector continues to evolve.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing collaboration between pharma and biotech firms to optimize midostaurin production and distribution across emerging markets
5.2. Expansion of midostaurin indications through clinical trials in pediatric acute myeloid leukemia populations
5.3. Rising integration of real-world evidence and patient registry data to support midostaurin reimbursement approvals
5.4. Emergence of combination regimens pairing midostaurin with novel FLT3 inhibitors to improve remission rates in AML
5.5. Growing focus on pricing strategies and value-based contracts for midostaurin in key Asia-Pacific healthcare systems
5.6. Advancements in companion diagnostic development to identify FLT3 mutations for targeted midostaurin therapy eligibility
5.7. Strategic licensing agreements with regional manufacturers to address midostaurin drug shortages and supply chain resilience
5.8. Digital health platforms enabling remote monitoring of hematological parameters among patients on midostaurin therapy
5.2. Expansion of midostaurin indications through clinical trials in pediatric acute myeloid leukemia populations
5.3. Rising integration of real-world evidence and patient registry data to support midostaurin reimbursement approvals
5.4. Emergence of combination regimens pairing midostaurin with novel FLT3 inhibitors to improve remission rates in AML
5.5. Growing focus on pricing strategies and value-based contracts for midostaurin in key Asia-Pacific healthcare systems
5.6. Advancements in companion diagnostic development to identify FLT3 mutations for targeted midostaurin therapy eligibility
5.7. Strategic licensing agreements with regional manufacturers to address midostaurin drug shortages and supply chain resilience
5.8. Digital health platforms enabling remote monitoring of hematological parameters among patients on midostaurin therapy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Midostaurin API Market, by Indication
8.1. Introduction
8.2. Acute Myeloid Leukemia
8.3. Systemic Mastocytosis
8.2. Acute Myeloid Leukemia
8.3. Systemic Mastocytosis
9. Midostaurin API Market, by Line Of Therapy
9.1. Introduction
9.2. First Line
9.3. Second Line And Beyond
9.2. First Line
9.3. Second Line And Beyond
10. Midostaurin API Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Retail Pharmacy
10.2. Hospital Pharmacy
10.3. Retail Pharmacy
11. Midostaurin API Market, by Formulation
11.1. Introduction
11.2. Intravenous
11.3. Oral
11.3.1. Capsule
11.3.2. Tablet
11.2. Intravenous
11.3. Oral
11.3.1. Capsule
11.3.2. Tablet
12. Midostaurin API Market, by Patient Type
12.1. Introduction
12.2. Adult
12.3. Pediatric
12.2. Adult
12.3. Pediatric
13. Americas Midostaurin API Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Midostaurin API Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Midostaurin API Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Aurobindo Pharma Limited
16.3.3. Viatris Inc.
16.3.4. Sun Pharmaceutical Industries Limited
16.3.5. Cipla Limited
16.3.6. Natco Pharma Limited
16.3.7. Jubilant Life Sciences Limited
16.3.8. Hetero Drugs Limited
16.3.9. Zydus Lifesciences Limited
16.3.10. Teva Pharmaceutical Industries Ltd.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Aurobindo Pharma Limited
16.3.3. Viatris Inc.
16.3.4. Sun Pharmaceutical Industries Limited
16.3.5. Cipla Limited
16.3.6. Natco Pharma Limited
16.3.7. Jubilant Life Sciences Limited
16.3.8. Hetero Drugs Limited
16.3.9. Zydus Lifesciences Limited
16.3.10. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. MIDOSTAURIN API MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MIDOSTAURIN API MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MIDOSTAURIN API MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MIDOSTAURIN API MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MIDOSTAURIN API MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MIDOSTAURIN API MARKET: RESEARCHAI
FIGURE 26. MIDOSTAURIN API MARKET: RESEARCHSTATISTICS
FIGURE 27. MIDOSTAURIN API MARKET: RESEARCHCONTACTS
FIGURE 28. MIDOSTAURIN API MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL MIDOSTAURIN API MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MIDOSTAURIN API MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MIDOSTAURIN API MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MIDOSTAURIN API MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MIDOSTAURIN API MARKET: RESEARCHAI
FIGURE 26. MIDOSTAURIN API MARKET: RESEARCHSTATISTICS
FIGURE 27. MIDOSTAURIN API MARKET: RESEARCHCONTACTS
FIGURE 28. MIDOSTAURIN API MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MIDOSTAURIN API MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MIDOSTAURIN API MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MIDOSTAURIN API MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MIDOSTAURIN API MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MIDOSTAURIN API MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SYSTEMIC MASTOCYTOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SYSTEMIC MASTOCYTOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SECOND LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SECOND LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MIDOSTAURIN API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MIDOSTAURIN API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MIDOSTAURIN API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MIDOSTAURIN API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MIDOSTAURIN API MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MIDOSTAURIN API MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MIDOSTAURIN API MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MIDOSTAURIN API MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 73. CANADA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. CANADA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. CANADA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 76. CANADA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 77. CANADA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. CANADA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. CANADA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. CANADA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. CANADA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 82. CANADA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 83. CANADA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. CANADA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. MEXICO MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. MEXICO MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. MEXICO MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 88. MEXICO MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 89. MEXICO MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. MEXICO MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. MEXICO MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. MEXICO MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 94. MEXICO MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 95. MEXICO MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 96. MEXICO MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 147. GERMANY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. GERMANY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. GERMANY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 150. GERMANY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 151. GERMANY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. GERMANY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. GERMANY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. GERMANY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. GERMANY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 156. GERMANY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 157. GERMANY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 158. GERMANY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 159. FRANCE MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. FRANCE MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. FRANCE MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 162. FRANCE MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 163. FRANCE MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. FRANCE MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. FRANCE MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. FRANCE MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. FRANCE MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 168. FRANCE MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 169. FRANCE MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 170. FRANCE MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 171. RUSSIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. RUSSIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 183. ITALY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. ITALY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. ITALY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 186. ITALY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 187. ITALY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. ITALY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. ITALY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. ITALY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. ITALY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 192. ITALY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 193. ITALY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ITALY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. SPAIN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. SPAIN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. SPAIN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 198. SPAIN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 199. SPAIN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SPAIN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SPAIN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. SPAIN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. SPAIN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 204. SPAIN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 205. SPAIN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 206. SPAIN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 222. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 234. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. DENMARK MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. DENMARK MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. DENMARK MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 246. DENMARK MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 247. DENMARK MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. DENMARK MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. DENMARK MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. DENMARK MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. DENMARK MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 252. DENMARK MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 253. DENMARK MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. DENMARK MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 258. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 259. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. QATAR MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. QATAR MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. QATAR MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 270. QATAR MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 271. QATAR MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. QATAR MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. QATAR MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. QATAR MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. QATAR MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 276. QATAR MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 277. QATAR MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. QATAR MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. FINLAND MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. FINLAND MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. FINLAND MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 282. FINLAND MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 283. FINLAND MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. FINLAND MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. FINLAND MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 286. FINLAND MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 287. FINLAND MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 288. FINLAND MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 289. FINLAND MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. FINLAND MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. SWEDEN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. SWEDEN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. SWEDEN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 294. SWEDEN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 295. SWEDEN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SWEDEN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 303. NIGERIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 304. NIGERIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 305. NIGERIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 306. NIGERIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. EGYPT MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. EGYPT MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. EGYPT MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 318. EGYPT MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 319. EGYPT MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. EGYPT MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. EGYPT MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 322. EGYPT MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 323. EGYPT MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 324. EGYPT MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 325. EGYPT MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 326. EGYPT MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 327. TURKEY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. TURKEY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. TURKEY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 330. TURKEY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 331. TURKEY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. TURKEY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. TURKEY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 334. TURKEY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 335. TURKEY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 336. TURKEY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 337. TURKEY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 338. TURKEY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 339. ISRAEL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. ISRAEL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. ISRAEL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 342. ISRAEL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 343. ISRAEL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. ISRAEL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. ISRAEL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 346. ISRAEL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 347. ISRAEL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 348. ISRAEL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 351. NORWAY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 352. NORWAY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 353. NORWAY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 354. NORWAY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 355. NORWAY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. NORWAY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. NORWAY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 358. NORWAY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 359. NORWAY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 360. NORWAY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 361. NORWAY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 362. NORWAY MIDOSTAURIN API MARKET SIZ
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MIDOSTAURIN API MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MIDOSTAURIN API MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MIDOSTAURIN API MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MIDOSTAURIN API MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SYSTEMIC MASTOCYTOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SYSTEMIC MASTOCYTOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SECOND LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MIDOSTAURIN API MARKET SIZE, BY SECOND LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MIDOSTAURIN API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MIDOSTAURIN API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MIDOSTAURIN API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MIDOSTAURIN API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MIDOSTAURIN API MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MIDOSTAURIN API MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MIDOSTAURIN API MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MIDOSTAURIN API MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MIDOSTAURIN API MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MIDOSTAURIN API MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MIDOSTAURIN API MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES MIDOSTAURIN API MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 73. CANADA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. CANADA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. CANADA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 76. CANADA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 77. CANADA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. CANADA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. CANADA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. CANADA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. CANADA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 82. CANADA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 83. CANADA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. CANADA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. MEXICO MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. MEXICO MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. MEXICO MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 88. MEXICO MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 89. MEXICO MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. MEXICO MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. MEXICO MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. MEXICO MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 94. MEXICO MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 95. MEXICO MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 96. MEXICO MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MIDOSTAURIN API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 147. GERMANY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. GERMANY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. GERMANY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 150. GERMANY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 151. GERMANY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. GERMANY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. GERMANY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. GERMANY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. GERMANY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 156. GERMANY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 157. GERMANY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 158. GERMANY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 159. FRANCE MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. FRANCE MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. FRANCE MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 162. FRANCE MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 163. FRANCE MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. FRANCE MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. FRANCE MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. FRANCE MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. FRANCE MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 168. FRANCE MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 169. FRANCE MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 170. FRANCE MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 171. RUSSIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. RUSSIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 183. ITALY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. ITALY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. ITALY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 186. ITALY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 187. ITALY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. ITALY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. ITALY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. ITALY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. ITALY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 192. ITALY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 193. ITALY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ITALY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. SPAIN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. SPAIN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. SPAIN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 198. SPAIN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 199. SPAIN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SPAIN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SPAIN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. SPAIN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. SPAIN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 204. SPAIN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 205. SPAIN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 206. SPAIN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 222. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 234. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. DENMARK MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. DENMARK MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. DENMARK MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 246. DENMARK MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 247. DENMARK MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. DENMARK MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. DENMARK MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. DENMARK MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. DENMARK MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 252. DENMARK MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 253. DENMARK MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. DENMARK MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 258. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 259. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. QATAR MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. QATAR MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. QATAR MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 270. QATAR MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 271. QATAR MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. QATAR MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. QATAR MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. QATAR MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. QATAR MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 276. QATAR MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 277. QATAR MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. QATAR MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. FINLAND MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. FINLAND MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. FINLAND MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 282. FINLAND MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 283. FINLAND MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. FINLAND MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. FINLAND MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 286. FINLAND MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 287. FINLAND MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 288. FINLAND MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 289. FINLAND MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. FINLAND MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. SWEDEN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. SWEDEN MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. SWEDEN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 294. SWEDEN MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 295. SWEDEN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SWEDEN MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 303. NIGERIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 304. NIGERIA MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 305. NIGERIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 306. NIGERIA MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. EGYPT MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. EGYPT MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. EGYPT MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 318. EGYPT MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 319. EGYPT MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. EGYPT MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. EGYPT MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 322. EGYPT MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 323. EGYPT MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 324. EGYPT MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 325. EGYPT MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 326. EGYPT MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 327. TURKEY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. TURKEY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. TURKEY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 330. TURKEY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 331. TURKEY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. TURKEY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. TURKEY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 334. TURKEY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 335. TURKEY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 336. TURKEY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 337. TURKEY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 338. TURKEY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 339. ISRAEL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. ISRAEL MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. ISRAEL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 342. ISRAEL MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 343. ISRAEL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. ISRAEL MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. ISRAEL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 346. ISRAEL MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 347. ISRAEL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 348. ISRAEL MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 351. NORWAY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 352. NORWAY MIDOSTAURIN API MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 353. NORWAY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 354. NORWAY MIDOSTAURIN API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 355. NORWAY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. NORWAY MIDOSTAURIN API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. NORWAY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 358. NORWAY MIDOSTAURIN API MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 359. NORWAY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 360. NORWAY MIDOSTAURIN API MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 361. NORWAY MIDOSTAURIN API MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 362. NORWAY MIDOSTAURIN API MARKET SIZ
Samples
LOADING...
Companies Mentioned
The companies profiled in this Midostaurin API Market report include:- Pfizer Inc.
- Aurobindo Pharma Limited
- Viatris Inc.
- Sun Pharmaceutical Industries Limited
- Cipla Limited
- Natco Pharma Limited
- Jubilant Life Sciences Limited
- Hetero Drugs Limited
- Zydus Lifesciences Limited
- Teva Pharmaceutical Industries Ltd.
